Prognostic value of morphology and hemodynamics in moyamoya disease for long-term outcomes and disease progression

Long Ma(Capital Medical University), Jizong Zhao(Capital Medical University), Chenglong Liu(Beijing Tian Tan Hospital), Peicong Ge(Capital Medical University), Zihan Yin(Zunyi Medical University), Xiaolong Ya(Beijing Tian Tan Hospital), Xun Ye(Capital Medical University), Yuanren Zhai(Capital Medical University), Chaofan Zeng(Capital Medical University), Dong Zhang(Capital Medical University), Junsheng Li(National Clinical Research Center for Digestive Diseases), Rong Wang(Capital Medical University), Qiheng He(Capital Medical University), Yan Zhang(American Academy of Cosmetic Surgery), Qian Zhang
Scientific Reports
November 15, 2024
10.1038/s41598-024-79608-4
Cited by 7

Related Papers

Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway
|Molecular Cancer|2011|102
Expression of Concern: Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor‐suppressive miR‐124
|FEBS Letters|2013|90